Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Leader Eye Drop Recall Issued over Bacterial Contamination Risks Adverse events have been reported in relation to the recalled Leader eye drops, which may be tainted with harmful bacteria. November 2, 2023 Katherine McDaniel Add Your Comments Following an eye drop contamination warning issued last week by federal regulators, Cardinal Health, Inc. has recalled multiple products sold under the brand name Leader, which may pose serious eye infection risks due to bacterial contamination. The U.S. Food and Drug Administration (FDA) announced the Leader eye drop recall on November 1, after agency investigators found unsanitary conditions in the manufacturing facility, and sample testing identified bacteria in critical drug production areas. As a result of the positive bacterial test results from the production site, the manufacturer has removed all lots of their eye drop products from the market. To date, the manufacturer and supplier have become aware of at least three complaints from consumers who experienced an adverse event or reaction after using the eye drops. Eye Drop Warning The recall follows an FDA advisory issued on October 27, which warned consumers that 26 different over-the-counter eye drop products sold under several popular brand names, including CVS, Target, and Rite Aid may contain harmful bacteria, which could cause severe eye infections that can potentially result in vision loss or permanent blindness. FDA officials released the consumer warning, and recommended the manufacturers issue a recall, after sample testing confirmed that the manufacturing site of Velocity Pharma, LLC, which supplied dozens of different eye drop products to several distributors, was unsterile and contained bacteria that posed vision-threatening infection risks to consumers. At the time of the warning, the agency indicated that CVS, Rite Aid, and Target were in the process of removing its products from store shelves and websites after becoming aware of the bacterial contamination. However, officials warned those distributed under Leader, Rugby, and Velocity brands were still available for purchase in stores or online, and should be avoided. Leader Eye Drops Recall The Leader recall impacts all lots of the following over-the-counter eye drop products distributed nationwide since December 12, 2021, with corresponding national drug codes (NDC) printed on the outer carton labeling: LEADER Eye Irritation Relief (Polyvinyl Alcohol, 0.5%, Povidone, 0.6%, and Tetrahydrozoline Hydrochloride, 0.05%), 0.5 FL OZ bottle (15 mL), NDC 70000-0087-1 LEADER Dry Eye Relief (Carboxymethylcellulose Sodium, 1%), 0.5 FL OZ bottle (15 mL), NDC 70000-0089-1 LEADER Lubricant Eye Drops (Carboxymethylcellulose Sodium, 0.5%), 0.5 FL OZ bottle (15 mL), NDC 70000-0090-1 LEADER Lubricant Eye Drops (Carboxymethylcellulose Sodium, 0.5%), 2 bottles, 0.5 FL OZ (15 mL) each, NDC 70000-0090-2 LEADER Dry Eye Relief (Polyethylene Glycol 400, 0.4% and Propylene Glycol, 0.3%), 0.33 FL OZ bottle (10 mL), 70000-0088-1 LEADER Lubricant Eye Drops (Propylene Glycol, 0.6%), 0.33 FL OZ bottle (10 mL), 70000-0587-1 Cardinal Health, Inc. announced that direct customer accounts impacted by the recall can expect an email notification to arrange for the return of the recalled products, and urged retailers to stop distributing them. The recall notice indicates consumers should discontinue use of the eye drops, and return them to their original place of purchase for a full refund. For more information on the recall, consumers may contact Sedgwick, Inc. by phone at 1-855-215-4940, Monday through Friday, from 8:00am-5:00pm EST, or by email at Cardinalhealth7720@sedgwick.com. The FDA also urges consumers to report any adverse reactions or quality issues they experienced after using the products to the FDA MedWatch Adverse Event Reporting Program. Artificial Tears Eye Drop Recall Lawsuits The recalls and warnings come as federal regulators have been conducting random sample testing of eye products, following recent manufacturing issues that have plagued the industry. EYE DROPS RECALL LAWSUITS Did you or a loved one use recalled eye drops? Lawyers are investigating EzriCare Artificial Tears lawsuits for individuals who experienced eye infections, blindness or other problems following use of the recalled eye drops. Learn More SEE IF YOU QUALIFY FOR COMPENSATION EYE DROPS RECALL LAWSUITS Did you or a loved one use recalled eye drops? Lawyers are investigating EzriCare Artificial Tears lawsuits for individuals who experienced eye infections, blindness or other problems following use of the recalled eye drops. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Earlier this year, a massive eye infection outbreak was linked to contaminated Artificial Tears eye drops, which were sold under the brands EzriCare and Delsam. An Artificial Tears recall was announced in February 2023, after dozens of users sustained severe bacterial infections, which resulted in several deaths. The eye drops were found to be contaminated with Carbapenem-Resistant Pseudomonas Aeruginosa (CRPA), a bacteria strain that can cause severe health consequences due to its antibiotic resistant and mutating capabilities. In severe cases, the bacteria strain is also known to cause endophthalmitis, a rare but serious infection of the eyeball that can destroy eye tissue and cause irreversible vision loss or permanent blindness. The recalled Artificial Tears eye drops have now been linked to at least 81 cases of bacterial eye infections, which has resulted in vision loss for multiple individuals, surgical eyeball removal for at least four consumers, and at least four deaths due to the contaminated products. Among former users of the contaminated eye drops, a growing number of Artificial Tears eye drop lawsuits are now being filed against the manufacturers and distributors of EzriCare and Delsam Pharma’s eye drops for multiple Pseudomonas aeruginosa infection injuries and side effects caused by the tainted products including; Eye Infection Partial Blindness Permanent Blindness Bloodstream Infection Other injuries caused by the eye drops Tags: Artificial Tears, Bacterial Contamination, Blindness, CVS, Delsam, Eye Drops, Eye Drops Recall, Ezricare, Infection, Target, Vision Loss More Eye Drops Recall Lawsuit Stories Lawsuit Alleges Infection From Recalled Eye Drops Caused Permanent Vision Damage, Light Sensitivity July 8, 2024 Eye Drops Vision Damage Lawsuit Filed Over Bacteria in Recalled Artificial Tears June 7, 2024 Amazon Artificial Tears Lawsuit Filed Over Bacterial Keratitis Infection from Contaminated Eye Drops February 15, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Lawsuit Alleges Infection From Recalled Eye Drops Caused Permanent Vision Damage, Light Sensitivity July 8, 2024
Amazon Artificial Tears Lawsuit Filed Over Bacterial Keratitis Infection from Contaminated Eye Drops February 15, 2024
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)